Finance

Beta
Lists
PPBT:NASDAQ
Purple Biotech Ltd - ADR
$3.09
0.00%
(0.00) 1D
$2.88
-6.80% (-0.21)
Pre-market
Closed: Jun 4, 4:00:00 PM GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for PPBT...
Mkt. cap
6.99M
Avg. vol.
226.58K
Volume
363.00
52-wk high
$29.00
52-wk low
$2.52
EPS
-$68.06
Beta
0.61
Shares outstanding
1.01M
No. of employees
10
Mkt. cap
6.99M
Avg. vol.
226.58K
Volume
363.00
52-wk high
$29.00
52-wk low
$2.52
EPS
-$68.06
Beta
0.61
Shares outstanding
1.01M
No. of employees
10
Analyst outlook
Analyst Ratings
Based on 1 analyst giving stock ratings to PPBT in the past 3 months
Buy
Buy
1
Hold
0
Sell
0
12 month forecast
Based on 1 Wall Street analyst offering 12 month price targets for PPBT in the last 3 months.
Highest
Current $3.09
$30.00 (+870.87%)
Average
$30.00 (+870.87%)
Lowest
$30.00 (+870.87%)
News stories
From sources across the web
About Purple Biotech Ltd - ADR
CEO-
Employees10
Founded1968
Headquarters-
SectorPharmaceutical industry
Websitepurple-biotech.com
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
Jun 2025
Sep 2025
Dec 2025
Mar 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
59.00K
-
Cost of revenue
-
-
59.00K
-
Research and development expenses
553.00K
587.00K
1.83M
1.23M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
683.00K
780.00K
1.08M
1.02M
Operating expense
1.24M
1.37M
2.90M
2.25M
Total operating expenses
1.24M
1.37M
2.96M
2.25M
Operating income
-1.24M
-1.37M
-2.96M
-2.25M
Other non operating income
74.00K
-56.00K
-223.00K
2.17M
EBT including unusual items
-1.09M
-1.30M
-23.64M
-89.00K
EBT excluding unusual items
-1.09M
-1.30M
-3.16M
-89.00K
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-1.08M
-1.30M
-23.54M
-86.00K
Net profit margin
-
-
-
-
Earnings per share
-4.00
2.90
-6.16
-2.33
Interest and investment income
73.00K
123.00K
16.00K
20.00K
Interest expense
-
-5.00K
-1.00K
-31.00K
Net interest expenses
73.00K
118.00K
15.00K
-11.00K
Depreciation and amortization charges
-
-
-
-
EBITDA
-1.19M
-1.31M
-2.91M
-2.19M
Gain or loss from assets sale
-
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer